Chargement en cours...
Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy
Lumacaftor-ivacaftor is a combination of two small molecule therapies targeting the basic defect in cystic fibrosis (CF) at a cellular level. It is a precision medicine and its effects are specific to individuals with two copies of the p.Phe508del gene mutation. The drug combination works by restori...
Enregistré dans:
| Publié dans: | Drug Des Devel Ther |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6650604/ https://ncbi.nlm.nih.gov/pubmed/31409974 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S153719 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|